CIHealthcarecigna.com
| Metric | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Mar 2026 | Jun 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $65.65B | $65.50B | $67.18B | $69.75B | $72.47B | $68.49B | $71.67B | $73.68B | ▲ +5.6% |
| Gross profit | $16.63B | $17.10B | $13.91B | $14.22B | $14.68B | $14.39B | $14.96B | $15.09B | ▲ +6.2% |
| Operating income | $2.17B | $1.97B | $2.31B | $2.58B | $2.35B | $2.36B | $2.68B | $2.40B | ▼ -7.1% |
| Net income | $1.54B | $1.32B | $1.53B | $1.87B | $1.23B | $1.65B | $1.66B | $1.44B | ▼ -22.8% |
| R&Dnever filed | — | — | — | — | — | — | — | — | — |
| EPS (diluted) | — | 4.85 $ | 5.71 $ | 6.98 $ | — | 6.26 $ | 6.29 $ | 5.47 $ | ▼ -21.6% |
| Margins (% of revenue) | |||||||||
| Gross | 25.3 % | 26.1 % | 20.7 % | 20.4 % | 20.3 % | 21.0 % | 20.9 % | 20.5 % | ▲ +0.1 pt |
| Operating | 3.3 % | 3.0 % | 3.4 % | 3.7 % | 3.2 % | 3.4 % | 3.7 % | 3.3 % | ▼ -0.4 pt |
| Net | 2.3 % | 2.0 % | 2.3 % | 2.7 % | 1.7 % | 2.4 % | 2.3 % | 2.0 % | ▼ -0.7 pt |
| Balance sheet | |||||||||
| Assets | $155.88B | $150.66B | $151.65B | $157.92B | $157.92B | $153.27B | $157.08B | $157.64B | ▼ -0.2% |
| Liabilities | $114.64B | $110.24B | $111.22B | $115.91B | $116.05B | $110.82B | $114.17B | $113.92B | ▼ -1.7% |
| Equity | $41.24B | $40.41B | $40.43B | $42.01B | $41.87B | $42.44B | $42.91B | $43.72B | ▲ +4.1% |
| Cash | $7.55B | $8.33B | $4.33B | $6.03B | $7.68B | $7.04B | $6.30B | $6.19B | ▲ +2.7% |
| Capital | |||||||||
| Shares outstanding | 273.68M | 267.14M | 266.93M | 267.13M | 263.53M | 264.53M | 264.24M | 263.50M | ▼ -1.4% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.